Your browser doesn't support javascript.
loading
Comprehensive genomic testing is required to assess for markers of poor prognosis in multiple myeloma.
Webb, Fiona; Talaulikar, Dipti.
Afiliação
  • Webb F; Department of Diagnostic Genomics, ACT Pathology, Canberra Health Services, Canberra, ACT, Australia.
  • Talaulikar D; Department of Diagnostic Genomics, ACT Pathology, Canberra Health Services, Canberra, ACT, Australia; Department of Haematology, ACT Pathology, Canberra Health Services, Canberra, ACT, Australia; Australian National University, Canberra, ACT, Australia. Electronic address: fiona.webb@act.gov.au.
Pathology ; 54(1): 111-113, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34154845
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article